-8%

Treviamet


Therapeutic Segment: Anti-Diabetic

Generic Name:- Sitagliptin phosphate monohydrate

                                 -Metformin HCI

KSh1,100 KSh1,200

For:

  • As initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control.
  • As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.
  • In triple combination with a sulphonylurea as an adjunct to diet and exercise in patients with type 2 diabetes mellitus inadequately controlled on their maximal tolera ted dose of Metformin HCl and a sulphonylurea.
  • In triple combination with a peroxisome proliferator-activated receptor gamma (PPARγ) agonist (thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of Metformin HCl and a PPARγ agonist.
  • In patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in combination with insulin.

Based on 0 reviews

0.0 overall
0
0
0
0
0

Be the first to review “Treviamet”

There are no reviews yet.

Start Chatting
1
Need help? Lets Chat!
Hello,
How can we help you today?